When cardiologists get involved in the treatment of patients with a history of cancer and newly diagnosed atrial fibrillation (AFib), those people see a subsequent 11 percent reduction in the risk of stroke, according to a new study in the Journal of the American College of Cardiology. But those visits occur less often for that subgroup of patients than in AFib patients without cancer.

Rapidly growing rates of obesity and diabetes—already threats to global health—will likely have fatal consequences in the case of a future flu pandemic, the Telegraph reported this week.

The GALILEO trial has been stopped after an early look at outcomes revealed rivaroxaban was associated with greater odds of thromboembolic events, all-cause death and bleeding events compared to antiplatelet therapy following transcatheter aortic valve replacement (TAVR).

A report published in Circulation: Cardiovascular Quality and Outcomes found a faith-based program in traditionally black churches was able to lower systolic blood pressure among attendants by an average 5.8 mm Hg—a result that more typical public education programs failed to replicate.

Patients who experience ischemic stroke in the posterior circulation are at greater risk of impaired functional outcomes compared to those with anterior circulation stroke (ACS)—particularly if their time to hospital arrival exceeds 4.5 hours, according to an Austrian registry study published Oct. 8 in Stroke.

Digoxin, a cardiac glycoside popularly sold under the brand name Lanoxin, poses a major threat to the heart health of atrial fibrillation (AF) and heart failure (HF) patients, according to a review published in the American Journal of Cardiology Oct. 4. Even without confounding conditions, the drug can raise an individual’s risk of all-cause mortality.

Half of women and a third of men will be diagnosed with stroke, dementia or parkinsonism in their lifetime, according to a nearly three-decades-long study of neurological disease in the Dutch population. Up to 50 percent of those cases, though, might be mitigated with early prevention.

Forearm blood flow is preserved two decades after coronary artery bypass graft (CABG) surgery using radial artery grafts, Australian researchers reported in a letter published in the Journal of the American College of Cardiology.